An Official Website of the United States Government
Company Information:
Name:
GAMMA THERAPEUTICS, INC.
Address:
2611 SW 3RD AVE, STE 280P
PORTLAND, OR 97201-4957
PORTLAND, OR 97201-4957
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Venous Thromboembolism Risk Marker Assay
Award Year / Program / Phase:
2010 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
David H. Farrell
Award Amount:
$514,223.00
Abstract:
DESCRIPTION (provided by applicant): The application's broad, long-term objectives are to develop a rapid, high-throughput clinical assay for 3' fibrinogen that will be used to assess the risk of a patient developing venous thromboembolism. This assay will
guide clinical management, particularly… More
Venous Thromboembolism Risk Marker Assay
Award Year / Program / Phase:
2011 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
David H. Farrell – 503-494-8602
Award Amount:
$1,048,970.00
Abstract:
DESCRIPTION (provided by applicant): The application's broad, long-term objectives are to develop a rapid, high-throughput clinical assay for 3' fibrinogen that will be used to assess the risk of a patient developing venous thromboembolism. This assay willguide clinical management,… More